Catalent (NYSE:CTLT) said today that it plans to fund its acquisition of soft-gel pharmaceutical capsule manufacturer Accucaps Industries Ltd with a $400 million debt offering.
The Somerset, N.J.-based company said the private placement offering of euro-dominated senior unsecured notes due in 2024 will also be used to repay some of the outstanding borrowings under its senior secured credit facilities, any accrued and unpaid interest, related fees and expenses.
Canada-based Accucaps has 2 facilities with high-potency prescription soft-gel development and manufacturing capabilities. Financial details of the acquisition have not been disclosed.
Get the full story at our sister site, Drug Delivery Business News.
The post Catalent to float $400m debt offering appeared first on MassDevice.